KPV
Lys-Pro-Val, α-MSH (11-13)
A tripeptide derived from alpha-melanocyte-stimulating hormone with potent anti-inflammatory, antimicrobial, and wound-healing properties.
Recruiting
NA
NCT06769100
Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery
McGill University
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06027632
Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer
Centre Francois Baclesse
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE1, PHASE2
NCT02264678
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
AstraZeneca
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT04389918
Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer
Stanford University
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT05409066
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
Genmab
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03353831
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
AGO Research GmbH
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT03752216
NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.
ARCAGY/ GINECO GROUP
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00098293
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
ViiV Healthcare
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT06260254
Effects of Railway Vibration on Sleep and Disease
Göteborg University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT03936257
Effect of an Innovative BIO Formula Intake on Infant Growth and Tolerance From 0 to 6 Months
Institut Pasteur de Lille
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01694849
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Genfit
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05319262
Metabolic and Cognitive Consequences of Noise-induced Sleep Disturbance
Göteborg University
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT04849728
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Inventiva Pharma
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT05214872
The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
Poznan University of Medical Sciences
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03598270
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NCT01818830
Amino Acids Expression Profiling of Patients With Sepsis
Chinese PLA General Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NA
NCT04076176
The Effects of CGMP in Children and Adults With PKU
Vitaflo International, Ltd
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT03017768
The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers
Universitaire Ziekenhuizen KU Leuven
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02700958
Remote Ischemic Preconditioning as a Method Against Subclinical Renal Injury and Contrast-induced Nephropathy
Tartu University Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT05201547
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
ARCAGY/ GINECO GROUP
INTERVENTIONAL
Updated Dec 15, 2025